Bucca C, Rolla G, Caria E, Arossa W, Bugiani M
Clinica Medica I dell'Universita' di Torino, Italy.
Eur Respir J. 1989 Mar;2(3):229-33.
Histamine bronchial threshold, the provocation concentration of histamine causing a 25% fall in maximal expiratory flow at 50% of forced vital capacity from the control value (PC25MEF50), was measured in seven heavy smokers and in seven sex- and age-matched nonsmokers before and one hour after ingestion, double-blind, of vitamin C (2 g) or placebo. Smokers had significantly lower baseline values of serum ascorbate, maximal expiratory flow at 50% of forced vital capacity (MEF50) and PC25MEF50: the latter was negatively related to serum ascorbate (r = -0.85; p less than 0.001). Acute treatment with vitamin C produced a significant decrease in PC25MEF50 in smokers (95% confidence limit (CL) from 4.87-3.36 to 2.91-2.01 mg.ml-1; p = 0.017), whilst it had no effect in nonsmokers. A preliminary open study on the effect of prolonged administration of vitamin C (1 g daily) was performed in smokers. One week of treatment produced a further significant decrease in PC25MEF50 (p less than 0.0001). Our results suggest that in heavy smokers histamine bronchial responsiveness may be attenuated by chronic ascorbate deficiency. In these circumstances, acute and short-term treatment with vitamin C may increase the bronchoconstrictive response to inhaled histamine.
在7名重度吸烟者以及7名年龄和性别匹配的不吸烟者中,在双盲条件下,于摄入维生素C(2克)或安慰剂之前及之后1小时,测量组胺支气管阈值,即导致用力肺活量50%时最大呼气流量从对照值下降25%的组胺激发浓度(PC25MEF50)。吸烟者的血清抗坏血酸基线值、用力肺活量50%时的最大呼气流量(MEF50)和PC25MEF50显著更低:后者与血清抗坏血酸呈负相关(r = -0.85;p < 0.001)。维生素C的急性治疗使吸烟者的PC25MEF50显著降低(95%置信区间(CL)从4.87 - 3.36降至2.91 - 2.01毫克·毫升⁻¹;p = 0.017),而对不吸烟者无影响。对吸烟者进行了一项关于长期服用维生素C(每日1克)效果的初步开放性研究。一周的治疗使PC25MEF50进一步显著降低(p < 0.0001)。我们的结果表明,在重度吸烟者中,组胺支气管反应性可能因慢性抗坏血酸缺乏而减弱。在这些情况下,维生素C的急性和短期治疗可能会增加对吸入组胺的支气管收缩反应。